Compagnie Lombard Odier SCmA’s GSK GSK Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-560	Closed	-$20K	–	612
2023 Q2	$20K	Hold	560	–	–	﹤0.01%	481
2023 Q1	$19.9K	Hold	560	–	–	﹤0.01%	518
2022 Q4	$20K	Hold	560	–	–	﹤0.01%	569
2022 Q3	$16K	Hold	560	–	–	﹤0.01%	537
2022 Q2	$30K	Hold	560	–	–	﹤0.01%	486
2022 Q1	$30K	Hold	560	–	–	﹤0.01%	489
2021 Q4	$31K	Hold	560	–	–	﹤0.01%	548
2021 Q3	$27K	Sell	560 -320	-36%	-$15.4K	﹤0.01%	540
2021 Q2	$44K	Hold	880	–	–	﹤0.01%	501
2021 Q1	$39K	Hold	880	–	–	﹤0.01%	531
2020 Q4	$40K	Hold	880	–	–	﹤0.01%	459
2020 Q3	$41K	Hold	880	–	–	﹤0.01%	386
2020 Q2	$45K	Sell	880 -3,600	-80%	-$184K	﹤0.01%	376
2020 Q1	$213K	Buy	4,480 +880	+24%	+$41.8K	0.01%	235
2019 Q4	$211K	Sell	3,600 -3,600	-50%	-$211K	0.01%	242
2019 Q3	$384K	Hold	7,200	–	–	0.02%	196
2019 Q2	$360K	Hold	7,200	–	–	0.01%	203
2019 Q1	$376K	Sell	7,200 -2,800	-28%	-$146K	0.02%	223
2018 Q4	$478K	Hold	10,000	–	–	0.02%	199
2018 Q3	$503K	Sell	10,000 -2,800	-22%	-$141K	0.02%	205
2018 Q2	$645K	Hold	12,800	–	–	0.02%	184
2018 Q1	$625K	Sell	12,800 -1,600	-11%	-$78.1K	0.02%	201
2017 Q4	$638K	Buy	14,400 +7,200	+100%	+$319K	0.01%	263
2017 Q3	$365K	Sell	7,200 -66	-0.9%	-$3.35K	0.01%	297
2017 Q2	$392K	Hold	7,266	–	–	0.01%	294
2017 Q1	$382K	Sell	7,266 -40,800	-85%	-$2.15M	0.01%	312
2016 Q4	$2.31M	Buy	48,066 +7,200	+18%	+$347K	0.07%	174
2016 Q3	$2.2M	Sell	40,866 -1,600	-4%	-$86.3K	0.06%	178
2016 Q2	$2.3M	Sell	42,466 -892	-2%	-$48.3K	0.07%	178
2016 Q1	$2.2M	Buy	43,358 +37,372	+624%	+$1.89M	0.07%	155
2015 Q4	$303K	Sell	5,986 -320	-5%	-$16.2K	0.01%	403
2015 Q3	$302K	Buy	6,306 +2,298	+57%	+$110K	0.01%	351
2015 Q2	$209K	Buy	4,008 +260	+7%	+$13.6K	0.01%	428
2015 Q1	$217K	Buy	+3,748	New	+$217K	0.01%	471
2014 Q1	–	Sell	-2,400	Closed	-$160K	–	878
2013 Q4	$160K	Buy	+2,400	New	+$160K	0.01%	570